Public Profile

Byondis B.V.

Byondis B.V., headquartered in the Netherlands, is a pioneering biopharmaceutical company specialising in the development of innovative antibody-drug conjugates (ADCs) for the treatment of cancer. Founded in 2013, Byondis has rapidly established itself as a key player in the oncology sector, focusing on targeted therapies that enhance the efficacy and safety of cancer treatments. With a strong presence in Europe and expanding operations in the United States, Byondis is committed to advancing its proprietary technologies, including its unique linker and payload systems. The company’s flagship product, a novel ADC, exemplifies its dedication to improving patient outcomes through precision medicine. Byondis has garnered recognition for its scientific advancements and strategic partnerships, positioning itself as a leader in the biopharmaceutical landscape.

DitchCarbon Score

How does Byondis B.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

24

Industry Benchmark

Byondis B.V.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Byondis B.V.'s reported carbon emissions

Byondis B.V., headquartered in the Netherlands, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their carbon footprint or climate initiatives. However, the company may be engaged in broader industry efforts to address climate change, aligning with global sustainability trends. As the landscape of corporate climate commitments evolves, Byondis B.V. may develop and disclose future strategies aimed at reducing their environmental impact.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Byondis B.V.'s primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Byondis B.V. is headquartered in NL, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Byondis B.V. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Similar Organizations

OSE Immunotherapeutics SA

FR
Health and social work services (85)
Updated 14 days ago

Bristol Myers Squibb

AE
Retail trade services, except of motor vehicles and motorcycles; repair services of personal and household goods (52)
Updated about 1 month ago
DitchCarbon Score

Zai Lab

CN
Research and development services (73)
Updated 14 days ago

Bio-Thera Solutions, Ltd.

CN
Health and social work services (85)
Updated 9 days ago

TESSA

FI
Other business services (74)
Updated 20 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers